Specific protein degradation is remaining explored as an alternative approach in cancer, whereby the normal protein degradation program is co-opted for therapeutic reasons. Just lately created novel molecules referred to as proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. Just one ligan